Legada, Bb Boy .

HRN: 21-63-47  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/27/2022
AMPICILLIN 250MG (VIAL)
07/27/2022
08/03/2022
IV
130 Mg
Q12Hrs
Neonatal Sepsis
Waiting Final Action 
07/27/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
07/27/2022
08/03/2022
IV
13 Mg
Q24 Hrs
Neonatal Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: